Help

BI’s Article search uses Boolean search capabilities. If you are not familiar with these principles, here are some quick tips.

To search specifically for more than one word, put the search term in quotation marks. For example, “workers compensation”. This will limit your search to that combination of words.

To search for a combination of terms, use quotations and the & symbol. For example, “hurricane” & “loss”.

International

Class-action lawsuit against Sanofi gets court’s nod

January 06, 2022 Reprints

A French court has recently allowed a class-action lawsuit over French biopharmaceutical company Sanofi SA’s epilepsy drug to proceed, France 24 reported citing AFP. The class-action was launched by the APESAC association in 2017 on behalf of the families of victims of Sanofi’s epilepsy drug Depakine, which, when consumed during pregnancy, allegedly caused severe malformations and neuro-development issues in children.

1. Turkish airlines cancel flights to Iran and Iraq amid war concerns
2. Zurich Insurance to stop underwriting new oil and gas projects
3. Bermudan, European reinsurers to suffer major hit from bridge collapse
4. Tycoon gets death sentence for multi-billion-dollar fraud
5. Inflation drives 10% increase in sum insured for windstorms
6. Apple loses bid to throw out $977M lawsuit over app store fees

Help

Class-action lawsuit against Sanofi gets court’s nod

Readers Poll

Most Read in International

Sign up now for free access to this article and much more.

If you are already registered with Business Insurance, click here to Login

Please tell us a bit more about yourself in order to continue

About

Advertise

Reprints and Licensing

Resources